PlainPharmaWatch

CMS Open Payments · Program Year 2024

Vascular Technology, Inc.

Vascular Technology, Inc. reported $943,229.00 in payments to 50 physicians and teaching hospitals across 50 transactions.

See the rankings → How this is sourced
$943.2K
Total payments
50
Transactions
50
Recipients
+$840.6K
General Payments vs PY2023

Vascular Technology, Inc. reported $943,229.00 in payments to 50 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #631 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $18.9K per recipient across 3 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Vascular Technology, Inc. pairs above-median payment volume with a concentrated payment pattern focused on a handful of top recipients.

#631
of 1,925 companies
0.0%
of all US industry payments
0.7%
paid to its single top recipient
3
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Vascular Technology, Inc.'s CMS-reported General Payments increased by $840.6K (+819.3%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: VASCULAR TECHNOLOGY, INC.PY2023: VASCULAR TECHNOLOGY, INC.PY2024: Vascular Technology, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$102.6KPY2024$943.2K
PY2023
$102,600.00
PY2024
$943,229.00

How Vascular Technology, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Vascular Technology, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$943,229 Top 33% higher than 67% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Vascular Technology, Inc.

$943,229.00: that is what Vascular Technology, Inc. reported in payments to 50 physicians and teaching hospitals during Program Year 2024, spread across 50 transactions ($18.9K per transaction, $18.9K per recipient). The company sits at rank #631 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 3 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $908.3K across 14 transactions, 96.3% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 3 types of general payments, Vascular Technology, Inc.'s largest category was "Compensation for Services Other Than Consulting" at $908.3K - 96.3% of the company's reported total.

How Vascular Technology, Inc. divides its payments

Ranked by total dollars reported per category

1. Compensation for Services…$908.3K2. Consulting Fee$33.9K3. Honoraria$1.1K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $908.3K 14
Consulting Fee $33.9K 33
Honoraria $1.1K 3

Recipient Concentration in General Payments

The five largest recipient relationships account for $932,260.00 (98.8%) of $943,229.00 in this company's General Payments records across 13 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Vascular Technology, Inc.

The five named recipients with the highest reported General Payments from this company

Michael Stifelman$672.5KJihad Kaouk$123.4KRonney Abaza$112.4KKeith Paige$12.0KJohn Marks$12.0K
  1. 1

    Michael Stifelman

    $672,460.00 across 1 reported transactions

  2. 2

    Jihad Kaouk

    $123,400.00 across 12 reported transactions

  3. 3

    Ronney Abaza

    $112,400.00 across 1 reported transactions

  4. 4

    Keith Paige

    $12,000.00 across 12 reported transactions

  5. 5

    John Marks

    $12,000.00 across 12 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $18.9K. Average per recipient: $18.9K.

Total Amount

$943,229.00

Avg per Transaction

$18.9K

Avg per Recipient

$18.9K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Vascular Technology, Inc. Share

0.0%

#631 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Vascular Technology, Inc.

Leica Microsystems Inc.

$942.6K 487 recipients

NS Pharma, Inc.

$942.1K 369 recipients

OrganOx Ltd

$944.6K 100 recipients

Heron Therapeutics, Inc.

$945.0K 4,695 recipients

Almirall LLC

$946.1K 5,128 recipients

Consortium of Independent Immunology Clinics, LLC

$938.8K 91 recipients

Frequently Asked Questions

How much did Vascular Technology, Inc. pay to physicians and hospitals in 2024? ▾
Vascular Technology, Inc. made $943,229.00 in payments to physicians and hospitals in Program Year 2024, across 50 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Vascular Technology, Inc.? ▾
Vascular Technology, Inc. made payments to 50 physicians and teaching hospitals in 2024. The average payment per recipient was $18.9K.
What types of payments did Vascular Technology, Inc. make? ▾
Vascular Technology, Inc. made 3 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Compensation for Services Other Than Consulting" at $908.3K, representing 96.3% of the company's reported total.
How does Vascular Technology, Inc. rank among pharmaceutical companies? ▾
Vascular Technology, Inc. ranks #631 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Vascular Technology, Inc.? ▾
The average transaction from Vascular Technology, Inc. was $18.9K in 2024. The company made 50 total transactions to 50 recipients.
Where does the payment data for Vascular Technology, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Vascular Technology, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.